Results. The PCR group of 116 patients (patients) were matched to 232 patients in IAT group (Table 1) . Positive results for influenza were reported in 37.9% of PCR vs. 18.1% of IAT groups (P < 0.001); hours in IAT group (P < 0.001). Oseltamivir was initiated in the ED in 21% of PCR vs. 11% of IAT group (P < 0.001). An additional 28% in PCR group received oseltamivir at ED discharge vs. 15% in IAT group (P = 0.004). Antibiotics were administered in the ED to 8% in PCR group vs. 15% in the IAT group. A positive influenza test was associated with less antibiotic use OR 0.454 (95% CI 0.213-0.967), while abnormal chest radiograph (CXR) and WBC was associated with increased antibiotic use OR 3.667 (95% CI 1.743-7.715). The 30-day revisit was 3.8% and 10.8% in the PCR vs. IAT groups, respectively (P = 0.034).
Background. Antimicrobial stewardship programs (ASPs) may improve patient outcomes by reducing antimicrobial adverse effects and resistance. Pneumonia is the most common infectious reason for hospitalization and is a key target for improvement in antimicrobial use. The purpose of this study was to measure the impact of a prospective audit and feedback program for patients with pneumonia in addition to an already robust pre-authorization program at an academic teaching hospital.
Methods. We analyzed the impact of a prospective audit and feedback initiative among inpatients with pneumonia treated with antimicrobials for at least 72 hours. The primary outcome was the percent of optimal antimicrobial days of therapy received based on hospital-approved pneumonia guidelines, compared pre-and postintervention. This outcome was defined as the number of optimal days of therapy compared with the total days of therapy over the entire study period from the hospital's perspective. Secondary outcomes included the incidence rate of optimal antimicrobial days of therapy on a patient-specific level, overall antimicrobial days of therapy, length of hospital stay, rates of Clostridium difficile infection (CDI), and in-hospital mortality.
Results. The study included 248 patients, 125 pre-and 123 postintervention. Forty interventions were made post-implementation, with duration (47.5%) and de-escalation (35%) recommendations most commonly suggested. 50.8% of patients were male, the median [interquartile range (IQR)] age was 71 (60-83) years old, 45.6% of patients had community-acquired pneumonia, and patients had a median (IQR) Elixhauser comorbidity score of 5 (3-6). The overall rate of guideline concordance was 65.8% pre-and 77.5% postintervention (P = 0.041). On an individual level, patients were 17% more likely to have optimal antimicrobials postintervention [Incidence rate ratio 1.17 (95% confidence interval 1.03-1.32, P = 0.013)]. Length of stay, days of therapy, CDI, and in-hospital mortality rates did not differ significantly between groups.
Conclusion. Initiating a prospective audit and feedback program in addition to pre-authorization led to a significant increase in concordance with hospital pneumonia guidelines, but no difference in secondary outcomes in our patient population. 
